DCF — DELRAY MEDICAL CENTER
Enterprise Value: $514.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$514.3M
Enterprise Value
$140.1M
PV of Cash Flows
$374.2M
PV of Terminal Value
$602.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $466.9M | $61.9M | 13.0% | $29.5M | $26.9M |
| Year 2 | $480.9M | $68.5M | 14.0% | $34.0M | $28.1M |
| Year 3 | $495.3M | $75.5M | 15.0% | $38.8M | $29.1M |
| Year 4 | $510.2M | $80.3M | 16.0% | $41.9M | $28.6M |
| Year 5 | $525.5M | $84.1M | 16.0% | $44.1M | $27.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $514.3M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$453.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.1274842225490284
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5